Global Companion Animal Postoperative Pain Management Therapeutics Market Size Study, by Animal, Product, Route of Administration, End-use, and Regional Forecasts 2022-2032

Description

The Global Companion Animal Postoperative Pain Management Therapeutics Market, valued at approximately USD 5.57 million in 2023, is projected to experience robust growth at a CAGR of 8.50% during the forecast period 2024-2032. With an ever-growing emphasis on improving animal health and welfare, the market for effective postoperative pain management solutions is gaining significant momentum globally. Therapeutics aimed at minimizing pain post-surgery are emerging as a vital part of veterinary medicine, reflecting a paradigm shift toward compassionate and evidence-based animal care.

The market's expansion is fueled by the increasing prevalence of surgical procedures among companion animals, driven by heightened awareness among pet owners and advancements in veterinary surgical practices. NSAIDs remain the most widely used products, attributed to their efficiency in reducing inflammation and alleviating pain. Meanwhile, anesthetics and opioids continue to play a crucial role in comprehensive pain management protocols, often tailored to individual animal needs. The advent of injectable options provides veterinarians with precise control over dosage and administration, enhancing treatment outcomes.

Despite the significant advancements, the market grapples with challenges such as regulatory barriers, the high cost of certain therapeutics, and the need for specialized training for veterinary practitioners. However, innovations in pain management technologies, coupled with an increase in e-commerce channels for veterinary products, are mitigating these issues. The rise of telemedicine in the veterinary sector is further enhancing the accessibility and adoption of these therapeutics, ensuring broader reach across various demographics.

North America commands a dominant position in the market, supported by well-established veterinary infrastructure, high pet adoption rates, and favorable reimbursement policies for veterinary procedures. Europe follows closely, underpinned by stringent animal welfare regulations and increasing adoption of companion animals. Meanwhile, the Asia Pacific region is anticipated to witness the fastest growth, fueled by urbanization, rising disposable incomes, and growing awareness regarding advanced veterinary care. Latin America and the Middle East & Africa present untapped opportunities, driven by improving veterinary healthcare infrastructure and expanding pet ownership.

Major market players included in this report are:

Zoetis Inc.
Elanco Animal Health
Merck Animal Health
Vetoquinol S.A.
Boehringer Ingelheim Animal Health
Ceva Sante Animale
Bayer Animal Health (now part of Elanco)
Virbac
Norbrook Laboratories
Dechra Pharmaceuticals
IDEXX Laboratories
Kindred Biosciences
Orion Corporation
Neogen Corporation
Animalcare Group plc

The detailed segments and sub-segment of the market are explained below:

By Animal:

Dogs
Cats
Horses
Others

By Product:

NSAIDs
Anesthetics
Opioids

By Route of Administration:

Oral
Injectable

By End-use:

Retail
E-Commerce
Veterinary Hospitals & Clinics

By Region: North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
Rest of Europe

Asia Pacific:

China
India
Japan
Australia
South Korea
Rest of Asia Pacific

Latin America:

Brazil
Mexico
Rest of Latin America

Middle East & Africa:

Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market estimates and forecasts spanning 2022-2032.
Comprehensive segmentation covering animals, products, administration routes, and end-use.
Detailed regional insights, including country-level analysis.
Profiles of major market players and their strategies.
Examination of market trends, challenges, and growth opportunities.

Chapter 1. Global Companion Animal Postoperative Pain Management Therapeutics Market Executive Summary

1.1. Global Companion Animal Postoperative Pain Management Therapeutics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Animal
  - 1.3.1.1. Dogs
  - 1.3.1.2. Cats
  - 1.3.1.3. Horses
  - 1.3.1.4. Others
- 1.3.2. By Product
  - 1.3.2.1. NSAIDs
  - 1.3.2.2. Anesthetics
  - 1.3.2.3. Opioids
- 1.3.3. By Route of Administration
  - 1.3.3.1. Oral
  - 1.3.3.2. Injectable
- 1.3.4. By End-use
  - 1.3.4.1. Retail
  - 1.3.4.2. E-Commerce
  - 1.3.4.3. Veterinary Hospitals & Clinics
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Companion Animal Postoperative Pain Management Therapeutics Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Companion Animal Postoperative Pain Management Therapeutics Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Prevalence of Surgical Procedures in Companion Animals
- 3.1.2. Advancements in Veterinary Medicine and Surgical Techniques
- 3.1.3. Rising Awareness Among Pet Owners Regarding Animal Welfare
3.2. Market Challenges
- 3.2.1. Regulatory Barriers and Compliance Issues
- 3.2.2. High Cost of Advanced Therapeutics
3.3. Market Opportunities
- 3.3.1. Expansion of E-Commerce Channels for Veterinary Products
- 3.3.2. Development of Cost-effective Pain Management Solutions
- 3.3.3. Growth in Telemedicine and Remote Veterinary Services

Chapter 4. Global Companion Animal Postoperative Pain Management Therapeutics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Companion Animal Postoperative Pain Management Therapeutics Market Size & Forecasts by Animal 2022-2032

5.1. Segment Dashboard
5.2. Global Companion Animal Postoperative Pain Management Therapeutics Market: Animal Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Dogs
- 5.2.2. Cats
- 5.2.3. Horses
- 5.2.4. Others

Chapter 6. Global Companion Animal Postoperative Pain Management Therapeutics Market Size & Forecasts by Product 2022-2032

6.1. Segment Dashboard
6.2. Global Companion Animal Postoperative Pain Management Therapeutics Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. NSAIDs
- 6.2.2. Anesthetics
- 6.2.3. Opioids

Chapter 7. Global Companion Animal Postoperative Pain Management Therapeutics Market Size & Forecasts by Route of Administration 2022-2032

7.1. Segment Dashboard
7.2. Global Companion Animal Postoperative Pain Management Therapeutics Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Oral
- 7.2.2. Injectable

Chapter 8. Global Companion Animal Postoperative Pain Management Therapeutics Market Size & Forecasts by End-use 2022-2032

8.1. Segment Dashboard
8.2. Global Companion Animal Postoperative Pain Management Therapeutics Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 8.2.1. Retail
- 8.2.2. E-Commerce
- 8.2.3. Veterinary Hospitals & Clinics

Chapter 9. Global Companion Animal Postoperative Pain Management Therapeutics Market Size & Forecasts by Region 2022-2032

9.1. North America Companion Animal Postoperative Pain Management Therapeutics Market
- 9.1.1. U.S. Companion Animal Postoperative Pain Management Therapeutics Market
  - 9.1.1.1. Animal Breakdown Size & Forecasts, 2022-2032
  - 9.1.1.2. Product Breakdown Size & Forecasts, 2022-2032
- 9.1.2. Canada Companion Animal Postoperative Pain Management Therapeutics Market
9.2. Europe Companion Animal Postoperative Pain Management Therapeutics Market
- 9.2.1. UK Companion Animal Postoperative Pain Management Therapeutics Market
- 9.2.2. Germany Companion Animal Postoperative Pain Management Therapeutics Market
- 9.2.3. France Companion Animal Postoperative Pain Management Therapeutics Market
- 9.2.4. Spain Companion Animal Postoperative Pain Management Therapeutics Market
- 9.2.5. Italy Companion Animal Postoperative Pain Management Therapeutics Market
- 9.2.6. Rest of Europe Companion Animal Postoperative Pain Management Therapeutics Market
9.3. Asia-Pacific Companion Animal Postoperative Pain Management Therapeutics Market
- 9.3.1. China Companion Animal Postoperative Pain Management Therapeutics Market
- 9.3.2. India Companion Animal Postoperative Pain Management Therapeutics Market
- 9.3.3. Japan Companion Animal Postoperative Pain Management Therapeutics Market
- 9.3.4. Australia Companion Animal Postoperative Pain Management Therapeutics Market
- 9.3.5. South Korea Companion Animal Postoperative Pain Management Therapeutics Market
- 9.3.6. Rest of Asia Pacific Companion Animal Postoperative Pain Management Therapeutics Market
9.4. Latin America Companion Animal Postoperative Pain Management Therapeutics Market
- 9.4.1. Brazil Companion Animal Postoperative Pain Management Therapeutics Market
- 9.4.2. Mexico Companion Animal Postoperative Pain Management Therapeutics Market
- 9.4.3. Rest of Latin America Companion Animal Postoperative Pain Management Therapeutics Market
9.5. Middle East & Africa Companion Animal Postoperative Pain Management Therapeutics Market
- 9.5.1. Saudi Arabia Companion Animal Postoperative Pain Management Therapeutics Market
- 9.5.2. South Africa Companion Animal Postoperative Pain Management Therapeutics Market
- 9.5.3. Rest of Middle East & Africa Companion Animal Postoperative Pain Management Therapeutics Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
- 10.1.1. Zoetis Inc.
- 10.1.2. Elanco Animal Health
- 10.1.3. Merck Animal Health
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Zoetis Inc.
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. Elanco Animal Health
- 10.3.3. Merck Animal Health
- 10.3.4. Vetoquinol S.A.
- 10.3.5. Boehringer Ingelheim Animal Health
- 10.3.6. Ceva Sante Animale
- 10.3.7. Bayer Animal Health (now part of Elanco)
- 10.3.8. Virbac
- 10.3.9. Norbrook Laboratories
- 10.3.10. Dechra Pharmaceuticals

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes